Avinash Singh

Avinash Singh

Active Director Director DIN 07659523
DIN 07659523 First appointment Dec 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2016
Shareholding value •••• Premium profile

About Avinash Singh

Data last updated:

Avinash Singh is a Director at Guerir Pharmaceuticals Private Limited (since 2016). The company operates in Pharma. Guerir Pharmaceuticals Private Limited reported revenue of ₹2.48 Cr (FY 2025).

DIN 07659523
Primary Designation Director
Industry Pharma
First Appointment 01 Dec 2016
Oldest Company Age 9 yrs
Largest company Guerir Pharmaceuticals Private Limited · ₹2.48 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Dec 20162016₹2.48 Cr (FY 2025)Active

Board colleagues of Avinash Singh

NameDINCompanyDesignation
Amit Singh08321930Guerir Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Guerir Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Avinash Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Avinash Singh

Avinash Singh currently holds 1 directorship: Guerir Pharmaceuticals Private Limited (Director, since 01 Dec 2016, revenue ₹2.48 Cr (FY 2025)).

Avinash Singh was first appointed on 01 Dec 2016 as Director at Guerir Pharmaceuticals Private Limited.

The current boards of Avinash Singh's companies include Amit Singh (Guerir Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available